1.Host metabolism dysregulation and cell tropism identification in human airway and alveolar organoids upon SARS-CoV-2 infection.
Rongjuan PEI ; Jianqi FENG ; Yecheng ZHANG ; Hao SUN ; Lian LI ; Xuejie YANG ; Jiangping HE ; Shuqi XIAO ; Jin XIONG ; Ying LIN ; Kun WEN ; Hongwei ZHOU ; Jiekai CHEN ; Zhili RONG ; Xinwen CHEN
Protein & Cell 2021;12(9):717-733
		                        		
		                        			
		                        			The coronavirus disease 2019 (COVID-19) pandemic is caused by infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is spread primary via respiratory droplets and infects the lungs. Currently widely used cell lines and animals are unable to accurately mimic human physiological conditions because of the abnormal status of cell lines (transformed or cancer cells) and species differences between animals and humans. Organoids are stem cell-derived self-organized three-dimensional culture in vitro and model the physiological conditions of natural organs. Here we showed that SARS-CoV-2 infected and extensively replicated in human embryonic stem cells (hESCs)-derived lung organoids, including airway and alveolar organoids which covered the complete infection and spread route for SARS-CoV-2 within lungs. The infected cells were ciliated, club, and alveolar type 2 (AT2) cells, which were sequentially located from the proximal to the distal airway and terminal alveoli, respectively. Additionally, RNA-seq revealed early cell response to virus infection including an unexpected downregulation of the metabolic processes, especially lipid metabolism, in addition to the well-known upregulation of immune response. Further, Remdesivir and a human neutralizing antibody potently inhibited SARS-CoV-2 replication in lung organoids. Therefore, human lung organoids can serve as a pathophysiological model to investigate the underlying mechanism of SARS-CoV-2 infection and to discover and test therapeutic drugs for COVID-19.
		                        		
		                        		
		                        		
		                        			Adenosine Monophosphate/therapeutic use*
		                        			;
		                        		
		                        			Alanine/therapeutic use*
		                        			;
		                        		
		                        			Alveolar Epithelial Cells/virology*
		                        			;
		                        		
		                        			Antibodies, Neutralizing/therapeutic use*
		                        			;
		                        		
		                        			COVID-19/virology*
		                        			;
		                        		
		                        			Down-Regulation
		                        			;
		                        		
		                        			Drug Discovery
		                        			;
		                        		
		                        			Human Embryonic Stem Cells/metabolism*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immunity
		                        			;
		                        		
		                        			Lipid Metabolism
		                        			;
		                        		
		                        			Lung/virology*
		                        			;
		                        		
		                        			RNA, Viral/metabolism*
		                        			;
		                        		
		                        			SARS-CoV-2/physiology*
		                        			;
		                        		
		                        			Virus Replication/drug effects*
		                        			
		                        		
		                        	
2.ISA 61 VG adjuvant enhances protective immune response of Listeria monocytogenes inactivated vaccine.
Tengfei ZHU ; Fanzeng MENG ; Hao YAO ; Yuting WANG ; Xin'an JIAO ; Yuelan YIN
Chinese Journal of Biotechnology 2020;36(7):1378-1385
		                        		
		                        			
		                        			Listeria monocytogenes (Lm) is zoonotic pathogen that can cause listeriosis, and vaccine is one of the effective methods to prevent this pathogen infection. In this study, we developed a novel vaccine that is a mixture of inactivated bacteria and Montanide™ ISA 61 VG, a mineral oil adjuvant, and evaluated the safety and immune response characteristics of this vaccine. The mice immunized with the ISA 61 VG adjuvant had high safety, and it could induce significantly higher titer of anti-listeriolysin O (LLO) antibody and higher value of IgG2a/IgG1 ratio compared with the group without the adjuvant. In particular, it could provide 100% immune protection against lethal doses of Lm challenge in mice. In summary, ISA 61VG adjuvant significantly enhanced the ability of inactivated listeria vaccine to induce humoral and cellular immune responses, thereby enhanced the protective immune response in the host, and it is a potential vaccine candidate for the prevention of Lm infection in humans and animals.
		                        		
		                        		
		                        		
		                        			Adjuvants, Immunologic
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Hemolysin Proteins
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			Immunity, Cellular
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			Listeria monocytogenes
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			Listeriosis
		                        			;
		                        		
		                        			prevention & control
		                        			;
		                        		
		                        			Mice
		                        			;
		                        		
		                        			Mice, Inbred BALB C
		                        			;
		                        		
		                        			Vaccines, Inactivated
		                        			;
		                        		
		                        			immunology
		                        			
		                        		
		                        	
3.Effect of ketotifen fumarate on experimental autoimmune orchitis and torsion of the spermatic cord.
Diego MORENO ; Cristian M SOBARZO ; Livia LUSTIG ; Marcelo G RODRÍGUEZ PEÑA ; Vanesa Anabella GUAZZONE
Asian Journal of Andrology 2020;22(1):112-117
		                        		
		                        			
		                        			The aim of this work was to study effects of ketotifen fumarate (KF) on prevention of tissue damage in testes of rats with experimental autoimmune orchitis (EAO) and on the contralateral testis in a model of prolonged testicular cord torsion (TCT). Rats with EAO or TCT were injected intraperitoneally once daily with KF or saline solution (vehicle group). Incidence and severity of testicular damage were evaluated by histopathology using an EAO score or a Johnsen score. Mast cells (MC) were identified by histochemistry and quantified. In EAO model, KF significantly reduced severity of histopathological testicular damage compared to rats in the vehicle group. KF also reduced the number of testicular MC compared to vehicle group. Similarly, in TCT model, multifocal damage of the contralateral testis was observed 30 days after testicular torsion characterized by sloughing of the germinal epithelium, seminiferous tubule atrophy, and interstitial edema. Focal signs of inflammation and fibrosis of seminiferous tubular walls were also observed. In contrast, sections of contralateral testis of rats injected with KF and killed 30 days after surgery showed normal histological features. A significant decrease in the number of MC was observed in rats treated with KF compared to untreated animals. In conclusion, we demonstrated that treatment with KF reduced testicular inflammatory process and MC infiltrates in both EAO and TCT models. The results suggest a promising treatment for infertile male patients with testicular pathologies associated with inflammation and germ cell loss.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Autoimmune Diseases/pathology*
		                        			;
		                        		
		                        			Cell Count
		                        			;
		                        		
		                        			Epididymis/pathology*
		                        			;
		                        		
		                        			Epididymitis/pathology*
		                        			;
		                        		
		                        			Histamine H1 Antagonists/pharmacology*
		                        			;
		                        		
		                        			Hypersensitivity, Delayed
		                        			;
		                        		
		                        			Immunity, Cellular/drug effects*
		                        			;
		                        		
		                        			Ketotifen/pharmacology*
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Mast Cells/pathology*
		                        			;
		                        		
		                        			Orchitis/pathology*
		                        			;
		                        		
		                        			Rats
		                        			;
		                        		
		                        			Severity of Illness Index
		                        			;
		                        		
		                        			Spermatic Cord Torsion/pathology*
		                        			;
		                        		
		                        			Testis/pathology*
		                        			;
		                        		
		                        			Vaccination
		                        			
		                        		
		                        	
4.Potential immunotherapies for traumatic brain and spinal cord injury.
Raj PUTATUNDA ; John R BETHEA ; Wen-Hui HU
Chinese Journal of Traumatology 2018;21(3):125-136
		                        		
		                        			
		                        			Traumatic injury of the central nervous system (CNS) including brain and spinal cord remains a leading cause of morbidity and disability in the world. Delineating the mechanisms underlying the secondary and persistent injury versus the primary and transient injury has been drawing extensive attention for study during the past few decades. The sterile neuroinflammation during the secondary phase of injury has been frequently identified substrate underlying CNS injury, but as of now, no conclusive studies have determined whether this is a beneficial or detrimental role in the context of repair. Recent pioneering studies have demonstrated the key roles for the innate and adaptive immune responses in regulating sterile neuroinflammation and CNS repair. Some promising immunotherapeutic strategies have been recently developed for the treatment of CNS injury. This review updates the recent progress on elucidating the roles of the innate and adaptive immune responses in the context of CNS injury, the development and characterization of potential immunotherapeutics, as well as outstanding questions in this field.
		                        		
		                        		
		                        		
		                        			Adaptive Immunity
		                        			;
		                        		
		                        			Astrocytes
		                        			;
		                        		
		                        			physiology
		                        			;
		                        		
		                        			Brain Injuries, Traumatic
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			therapy
		                        			;
		                        		
		                        			Histone Deacetylases
		                        			;
		                        		
		                        			therapeutic use
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immunity, Innate
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			Immunotherapy
		                        			;
		                        		
		                        			methods
		                        			;
		                        		
		                        			Inflammasomes
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			physiology
		                        			;
		                        		
		                        			Macrophage Activation
		                        			;
		                        		
		                        			Spinal Cord Injuries
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			therapy
		                        			
		                        		
		                        	
5.Effects of Gardenia jasminoides extracts on cognition and innate immune response in an adult Drosophila model of Alzheimer's disease.
Wei-Wei MA ; Ye TAO ; Yan-Ying WANG ; I-Feng PENG
Chinese Journal of Natural Medicines (English Ed.) 2017;15(12):899-904
		                        		
		                        			
		                        			Herbal extracts have been extensively used worldwide for their application on memory improvement, especially among aged and memory-deficit populations. In the present study, the memory loss induced by human Abeta protein over-expression in fruitfly Alzheimer's disease (AD) model was rescued by multiple extracts from Gardenia jasminoides. Three extracts that rich with gardenia yellow, geniposide, and gardenoside components showed distinct rescue effect on memory loss. Further investigation on adding gardenoside into a formula of Ganoderma lucidum, Panax notoginseng and Panax ginseng (GPP) also support its therapeutic effects on memory improvement. Interestingly, the application of GPP and gardenoside did not alter the accumulation of Abeta proteins but suppressed the expression of immune-related genes in the brain. These results revealed the importance and relevancy of anti-inflammation process and the underlying mechanisms on rescuing memory deficits, suggesting the potential therapeutic use of the improved GPP formulation in improving cognition in defined population in the future.
		                        		
		                        		
		                        		
		                        			Alzheimer Disease
		                        			;
		                        		
		                        			drug therapy
		                        			;
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Antimicrobial Cationic Peptides
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			Brain
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			Cognition
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			Disease Models, Animal
		                        			;
		                        		
		                        			Drosophila
		                        			;
		                        		
		                        			Drosophila Proteins
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			Gardenia
		                        			;
		                        		
		                        			chemistry
		                        			;
		                        		
		                        			Gene Expression Regulation
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			Immunity, Innate
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			Iridoids
		                        			;
		                        		
		                        			chemistry
		                        			;
		                        		
		                        			isolation & purification
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			Plant Extracts
		                        			;
		                        		
		                        			chemistry
		                        			;
		                        		
		                        			isolation & purification
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			Polymerase Chain Reaction
		                        			
		                        		
		                        	
6.Effects of Blending Oil of Lavender and Thyme on Oxidative Stress, Immunity, and Skin Condition in Atopic Dermatitis Induced Mice.
Journal of Korean Academy of Nursing 2015;45(3):367-377
		                        		
		                        			
		                        			PURPOSE: The purpose of this study was to evaluate the effects of essential oil on oxidative stress, immunity, and skin condition in atopic dermatitis (AD) induced mice. METHODS: This study was a 3x3 factorial design. Factors were oil type (Lavender, Thyme, and 2:1 mixture of lavender and thyme oil [blending oil]) and treatment period (0 day, 7 days, and 21 days). The samples were 45 mice with AD and randomly assigned to nine groups of five mice per group. The dependent variables such as superoxide radical, IgE, degranulated mast cells, and epidermal thickness were measured. Data were collected from February to April in 2014. Descriptive statistics, One-way ANOVA, Two-way ANOVA, and Tukey's HSD test were performed using the SPSS WIN 20.0 program. RESULTS: Dependent variables were not statistically significantly different by the three oil types (p >.05). Essential oils such as lavender, thyme, and blending oil were all effective in reducing AD symptoms and especially 2:1 blending oil were most effective. There were statistically significant differences by the three treatment periods in all dependent variables (p <.001). There were statistically significant interactions between oil types and treatment periods in all dependent variables (p <.01). For decreasing superoxide radical, degranulated mast cells, and epidermal thickness, 2:1 mixed oil should be applied for at least 21 days. Otherwise to reduce IgE, 2:1 mixed oil should be used for at least 7 days. CONCLUSION: These findings provide bases for developing effective interventions for AD patients to manage their AD symptoms.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Dermatitis, Atopic/chemically induced/*drug therapy/pathology
		                        			;
		                        		
		                        			Disease Models, Animal
		                        			;
		                        		
		                        			*Immunity/drug effects
		                        			;
		                        		
		                        			Immunoglobulin E/blood
		                        			;
		                        		
		                        			Lavandula/*chemistry/metabolism
		                        			;
		                        		
		                        			Mast Cells/cytology/metabolism
		                        			;
		                        		
		                        			Mice
		                        			;
		                        		
		                        			Oils, Volatile/chemistry/pharmacology/therapeutic use
		                        			;
		                        		
		                        			*Oxidative Stress/drug effects
		                        			;
		                        		
		                        			Picryl Chloride/toxicity
		                        			;
		                        		
		                        			Plant Oils/chemistry/pharmacology/*therapeutic use
		                        			;
		                        		
		                        			Singlet Oxygen/metabolism
		                        			;
		                        		
		                        			Skin/drug effects/pathology
		                        			;
		                        		
		                        			Thymus Plant/*chemistry/metabolism
		                        			
		                        		
		                        	
7.Progress in Research on Structure, Function and Antiviral of Enterovirus A71 3C Protein.
Jing LI ; Hongling WEN ; Zhiyu WANG
Chinese Journal of Virology 2015;31(4):468-473
		                        		
		                        			
		                        			Enterovirus A71 (EV-A71) causes hand, foot, and mouth disease (HFMD) and various neurological complications, including aseptic meningitis and neurogenic pulmonary edema in young children. HFMD caused by EV-A71 have broken out several times in the Asia-Pacific region since 2007. And it has been a serious threat to public health. There is no effective vaccine or antiviral drug. The pathogenesis of EV-A71 infection is unknown, and EV-A71 3C protein plays an irreplaceable role in replication and anti - innate immunity. Further research on EV-A71 3C protein is conducive to understand the pathogenesis of EV-A71 infection and antiviral drug.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Antiviral Agents
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			Enterovirus
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			physiology
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immunity, Innate
		                        			;
		                        		
		                        			Viral Proteins
		                        			;
		                        		
		                        			chemistry
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Virus Replication
		                        			;
		                        		
		                        			drug effects
		                        			
		                        		
		                        	
8.Effects of astragalus polysaccharide on intestinal immune function of rats with severe scald injury.
Cuilan HUANG ; Jianhua ZHAN ; Jinhua LUO
Chinese Journal of Burns 2015;31(1):30-36
OBJECTIVETo observe the effects of astragalus polysaccharide (AP) on the intestinal mucosal morphology, level of secretory IgA (s-IgA) in intestinal mucus, and distribution of T lymphocyte subsets in Peyer's patch in rats with severe scald injury.
METHODSOne hundred and thirty SD rats were divided into sham injury group (SI, sham injured, n = 10), scald group (S, n = 30), low dosage group (LD, n = 30), moderate dosage group (MD, n = 30), and high dosage group (HD, n = 30) according to the random number table. Rats in the latter 4 groups were inflicted with 30% TBSA full-thickness scald on the back. From post injury hour 2, rats in groups LD, MD, and HD were intraperitoneally injected with 0.5 mL AP solution with the dosage of 100, 200, and 300 mg/kg each day respectively, and rats in group S were injected with 0.5 mL normal saline instead. Ten rats from group SI immediately after injury and 10 rats from each of the latter 4 groups on post injury day (PID) 3, 7, 14 were sacrificed, and their intestines were harvested. The morphology of ileal mucosa was examined after HE staining; the level of s-IgA in ileal mucus was determined with double-antibody sandwich ELISA method; the proportions of CD3⁺, CD4⁺, CD8⁺ T lymphocytes in Peyer's patches of intestine were determined with flow cytometer, and the proportion of CD4⁺ to CD8⁺ was calculated. Data were processed with one-way analysis of variance, analysis of variance of factorial design, and SNK test.
RESULTS(1) Villi in normal form and intact villus epithelial cells were observed in rats of group SI immediately after injury, while edema of villi and necrosis and desquamation of an enormous amount of villi were observed in groups with scalded rats on PID 3, with significant infiltration of inflammatory cells. On PID 7, no obvious improvement in intestinal mucosal lesion was observed in groups with scalded rats. On PID 14, the pathology in intestinal mucosa of rats remained nearly the same in group S, and it was alleviated obviously in groups LD and MD, and the morphology of intestinal mucosa of rats in group HD was recovered to that of group SI. (2) On PID 3, 7, and 14, the level of s-IgA in intestinal mucus significantly decreased in groups S, LD, MD, and HD [(43 ± 5), (45 ± 5), (46 ± 5) µg/mL; (47 ± 5), (48 ± 5), (49 ± 6) µg/mL; (50 ± 6), (51 ± 5), (52 ± 5) µg/mL; (53 ± 6), (54 ± 5), (55 ± 5) µg/mL] as compared with that of rats in group SI immediately after injury [(69 ± 4) µg/mL, with P values below 0.05]. The level of s-IgA in intestinal mucus of rats in group MD was significantly higher than that in group S at each time point (with P values below 0.05), and that of group HD was significantly higher than that in groups S and LD at each time point (with P values below 0.05). (3) Compared with those of rats in group SI immediately after injury, the proportions of CD3⁺ T lymphocytes and CD4⁺ T lymphocytes significantly decreased in groups with scalded rats at each time point (with P values below 0.05), except for those in group HD on PID 14. The proportion of CD4⁺ T lymphocytes of rats in group LD was significantly higher than that in group S on PID 3 (P < 0.05). The proportions of CD3⁺ T lymphocytes and CD4⁺ T lymphocytes were significantly higher in groups MD and HD than in groups S and LD (except for the proportion of CD4⁺ T lymphocytes in group MD on PID 3 and 14) at each time point (with P values below 0.05). The proportion of CD3⁺ T lymphocytes on PID 7 and 14 and that of CD4⁺ T lymphocytes on PID 3 were significantly higher in group HD than in group MD (with P values below 0.05). Compared with that of rats in group SI immediately after injury, the proportion of CD8⁺ T lymphocytes significantly increased in the other 4 groups at each time point (with P values below 0.05). The proportion of CD8⁺ T lymphocytes was significantly lower in rats of group LD on PID 7 and 14 and groups MD and HD at each time point than in group S (with P values below 0.05). The proportion of CD8⁺ T lymphocytes was significantly lower in rats of group MD on PID 7 and 14 and group HD at each time point than in group LD (with P values below 0.05). The proportion of CD8⁺ T lymphocytes was significantly lower in rats of group HD on PID 7 and 14 than in group MD (with P values below 0.05). On PID 3, 7, and 14, the proportion of CD4⁺ to CD8⁺ was significantly lower in groups S, LD, MD, and HD (0.65 ± 0.11, 0.68 ± 0.13, 0.73 ± 0.22; 0.76 ± 0.15, 0.78 ± 0.14, 0.90 ± 0.10; 0.85 ± 0.21, 0.89 ± 0.18, 1.08 ± 0.19; 0.99 ± 0.20, 1.05 ± 0.21, 1.25 ± 0.23) as compared with that of rats in group SI immediately after injury (1.74 ± 0.20, with P values below 0.05). The proportion of CD4⁺ to CD8⁺ was significantly higher in rats of group HD than in group MD on PID 7 (P < 0.05), and the proportion was significantly higher in these two groups than in group S at each time point (with P values below 0.05). The proportion of CD4⁺ to CD8⁺ was significantly higher in rats of group MD on PID 14 and group HD at each time point than in group LD (with P values below 0.05). Compared within each group, the proportions of CD3⁺, CD4⁺, CD8⁺ T lymphocytes and the proportion of CD4⁺ to CD8⁺ of rats in groups LD, MD, and HD showed a trend of gradual elevation along with passage of time.
CONCLUSIONSAP can improve the injury to intestinal mucosa and modulate the balance of T lymphocyte subsets in Peyer's patch in a time- and dose-dependent manner, and it can promote s-IgA secretion of intestinal mucosa in a dose-dependent manner.
Animals ; Astragalus Plant ; adverse effects ; Burns ; immunology ; pathology ; physiopathology ; Dose-Response Relationship, Drug ; Immunity, Mucosal ; Immunoglobulin A ; metabolism ; Intestinal Mucosa ; metabolism ; physiology ; Intestine, Small ; metabolism ; Peyer's Patches ; immunology ; physiopathology ; Polysaccharides ; Rats ; Rats, Sprague-Dawley ; Soft Tissue Injuries ; T-Lymphocyte Subsets ; immunology
9.Effect of Culture Supernatant Derived from Trichophyton Rubrum Grown in the Nail Medium on the Innate Immunity-related Molecules of HaCaT.
Xin-Zhu HUANG ; Pan-Pan LIANG ; Han MA ; Jin-Ling YI ; Song-Chao YIN ; Zhi-Rui CHEN ; Mei-Rong LI ; Wei LAI ; Jian CHEN
Chinese Medical Journal 2015;128(22):3094-3100
BACKGROUNDTrichophyton rubrum is superficial fungi characteristically confined to dead keratinized tissues. These observations suggest that the soluble components released by the fungus could influence the host immune response in a cell in contact-free manner. Therefore, this research aimed to analyze whether the culture supernatant derived from T. rubrum grown in the nail medium could elicit the immune response of keratinocyte effectively.
METHODSThe culture supernatants of two strains (T1a, T XHB ) were compared for the β-glucan concentrations and their capacity to impact the innate immunity of keratinocytes. The β-glucan concentrations in the supernatants were determined with the fungal G-test kit and protein concentrations with bicinchoninic acid protein quantitative method, then HaCaT was stimulated with different concentrations of culture supernatants by adopting morphological method to select a suitable dosage. Expressions of host defense genes were assessed by quantitative polymerase chain reaction after the HaCaT was stimulated with the culture supernatants. Data were analyzed with one-way analysis of variance, followed by the least significant difference test.
RESULTSThe T. rubrum strains (T1a and T XHB ) released β-glucan of 87.530 ± 37.581 pg/ml and 15.747 ± 6.453 pg/ml, respectively into the media. The messenger RNA (mRNA) expressions of toll-like receptor-2 (TLR2), TLR4, and CARD9 were moderately up-regulated in HaCaT within 6-h applications of both supernatants. HaCaT cells were more responsive to T1a than T XHB . The slight increase of dendritic cells-specific intercellular adhesion molecule 3-grabbing nonintegrin expression was faster and stronger, induced by T1a supernatant than T XHB . The moderate decreases of RNase 7, the slight up-regulations of Dectin-1 and interleukin-8 at the mRNA level were detected only in response to T1a rather than T XHB . After a long-time contact, all the elevated defense genes decreased after 24 h.
CONCLUSIONThe culture supernatant of T. rubrum could directly and transiently activate the innate immune response of keratinocytes.
Cell Line, Tumor ; Culture Media, Conditioned ; pharmacology ; Humans ; Immunity, Innate ; drug effects ; Keratinocytes ; drug effects ; metabolism ; Trichophyton ; metabolism ; beta-Glucans ; metabolism
10.The polysaccharide isolated from Pleurotus nebrodensis (PN-S) shows immune-stimulating activity in RAW264.7 macrophages.
Hai-Yan CUI ; Chang-Lu WANG ; Yu-Rong WANG ; Zhen-Jing LI ; Ya-Nan ZHANG
Chinese Journal of Natural Medicines (English Ed.) 2015;13(5):355-360
		                        		
		                        			
		                        			A novel Pleurotus nebrodensis polysaccharide (PN-S) was purified and characterized, and its immune-stimulating activity was evaluated in RAW264.7 macrophages. PN-S induced the proliferation of RAW264.7 cells in a dose-dependent manner, as determined by the MTT assay. After exposure to PN-S, the phagocytosis of the macrophages was significantly improved, with remarkable changes in morphology being observed. Flow cytometric analysis demonstrated that PN-S promoted RAW264.7 cells to progress through S and G2/M phases. PN-S treatment enhanced the productions of interleukin-6 (IL-6), nitric oxide (NO), interferon gamma (INF-γ), and tumor necrosis factor-α (TNF-α) in the macrophages, with up-regulation of mRNA expressions of interleukin-6 (IL-6), inducible nitric oxide synthase (iNOS), interferon gamma(INF-γ) and tumor necrosis factor-α (TNF-α) being observed in a dose-dependent manner, as measured by qRT-PCR. In conclusion, these results suggest that the purified PN-S can improve immunity by activating macrophages.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Cell Cycle
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			Cell Line
		                        			;
		                        		
		                        			Cell Proliferation
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			Fungal Polysaccharides
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			Immunity
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			Interferon-gamma
		                        			;
		                        		
		                        			biosynthesis
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Interleukin-6
		                        			;
		                        		
		                        			biosynthesis
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Macrophages
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Mice
		                        			;
		                        		
		                        			Nitric Oxide
		                        			;
		                        		
		                        			biosynthesis
		                        			;
		                        		
		                        			Nitric Oxide Synthase Type II
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Pleurotus
		                        			;
		                        		
		                        			RNA, Messenger
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Reverse Transcriptase Polymerase Chain Reaction
		                        			;
		                        		
		                        			Tumor Necrosis Factor-alpha
		                        			;
		                        		
		                        			biosynthesis
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Up-Regulation
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail